Dimethyl Fumarate Capsule, Delayed Release
Product Images NDC 16729-417

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dimethyl Fumarate (NDC 16729-417). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (120 mg Capsules: Box Label)

Principal Display Panel (120 mg Capsules: Box Label)
Label for Dimethyl Fumarate 120 mg delayed-release capsules by Accord Healthcare Inc. The label states the dosage form as delayed-release capsules, with each capsule containing 120 mg of dimethyl fumarate. The package contains 14 capsules. Manufacturer details include Accord Healthcare, Inc., Durham, NC, and Intas Pharmaceuticals Limited, Ahmedabad, India. Storage instructions and a barcode are also visible.*
FDA Label Image

Principal Display Panel (240 mg Capsules: Box Label)

Principal Display Panel (240 mg Capsules: Box Label)
Drug facts label for Dimethyl Fumarate delayed-release capsules, 240 mg strength. The label includes dosage information, storage instructions, manufacturer details, package quantity of 46 capsules, and the Accord Healthcare Inc. branding. It instructs to swallow the capsule whole and notes prescription use only.*
FDA Label Image

Figure 1 (Dmf Figure1)

Figure 1 (Dmf Figure1)
A line graph depicting the percentage of subjects with confirmed progression of disability over time in weeks (up to 96 weeks). Two lines show comparative data for Placebo (n=408) and Dimethyl fumarate 240 mg BID (n=409). The y-axis reflects the percentage of subjects, with final values of approximately 27.1% for Placebo and 16.4% for Dimethyl fumarate.*
FDA Label Image

Principal Display Panel (Starter Pack: Box Label)

Principal Display Panel (Starter Pack: Box Label)
Packaging label for Dimethyl Fumarate delayed-release capsules by Accord Healthcare Inc. The label details a 30-day starter pack with two bottles: one containing 14 capsules of 120 mg for the starter dose and another with 46 capsules of 240 mg for the regular dose. Storage instructions and usage notes are also included.*
FDA Label Image

Structural Formula (Dmf Structure)

Structural Formula (Dmf Structure)
Chemical structure of Dimethyl fumarate, showing its molecular configuration with carbon, hydrogen, and oxygen atoms arranged in a fumarate ester form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.